Profile data is unavailable for this security.
About the company
ImmuneOnco Biopharmaceuticals Shanghai Inc is a China-based company mainly engaged in research and development of testing biotechnology. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in HKD (TTM)404.97k
- Net income in HKD-402.17m
- Incorporated2015
- Employees150.00
- LocationImmuneOnco Biopharmaceuticals Shanghai IncSHANGHAI ChinaCHN
- Phone+86 2 138016387
- Websitehttp://immuneonco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mabpharm Ltd | 162.87m | -222.28m | 1.38bn | 297.00 | -- | 11.17 | -- | 8.48 | -0.0539 | -0.0539 | 0.0395 | 0.03 | 0.164 | 0.1937 | 3.26 | 469,376.20 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -22.44 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| TOT Biopharm International Co Ltd | 1.05bn | 9.63m | 1.46bn | 572.00 | 142.35 | 1.88 | 21.41 | 1.40 | 0.0133 | 0.0133 | 1.44 | 1.01 | 0.6899 | 2.44 | 6.40 | 1,897,227.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Hua Medicine | 117.02m | -282.92m | 1.65bn | 172.00 | -- | -- | -- | 14.07 | -0.2886 | -0.2886 | 0.1194 | -0.0363 | 0.0779 | 1.51 | 3.31 | 661,157.10 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Qyuns Therapeutics Co Ltd | 48.25m | -453.10m | 1.98bn | 325.00 | -- | 5.02 | -- | 41.10 | -1.93 | -1.93 | 0.219 | 1.78 | -- | -- | -- | 145,775.50 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -29.56 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Frontage Holdings Corp | 2.02bn | 47.47m | 2.18bn | 1.66k | 46.60 | 0.8315 | 6.44 | 1.08 | 0.023 | 0.023 | 0.988 | 1.29 | 0.4701 | 56.23 | 4.58 | 1,150,374.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.37 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 859.97m | -261.91m | 2.40bn | 1.04k | -- | 3.02 | -- | 2.79 | -0.6576 | -0.6576 | 2.16 | 1.99 | 0.3109 | 23.64 | 5.36 | 806,728.50 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -4.18 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CStone Pharmaceuticals | 490.40m | -152.87m | 2.56bn | 164.00 | -- | 5.09 | -- | 5.21 | -0.12 | -0.12 | 0.3847 | 0.3912 | 0.2861 | 1.33 | 2.50 | 2,132,195.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 404.97k | -402.17m | 2.74bn | 150.00 | -- | 4.25 | -- | 6,772.28 | -1.12 | -1.12 | 0.0011 | 1.72 | -- | -- | -- | 2,792.90 | -- | -- | -- | -- | -- | -- | -99,307.43 | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Abbisko Cayman Ltd | 534.17m | -17.40m | 3.15bn | 275.00 | -- | 1.41 | 886.04 | 5.89 | -0.0295 | -0.0295 | 0.8225 | 3.27 | 0.2159 | -- | 65.75 | 2,070,417.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to ImmuneOnco Biopharmaceuticals Shanghai Inc's reporting currency: Hong Kong Dollar HKD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management (Hong Kong) Ltd.as of 30 Sep 2024 | 21.43k | 0.01% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 800.00 | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 600.00 | 0.00% |
Data from 30 Sep 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.
